Mp83-20 an Assessment of Immune Checkpoint Expression Among Patients With Nmibc Undergoing Intravesical Bcg: Implications for Ongoing Randomized Trials.

Journal of Urology - Netherlands
doi 10.1016/j.juro.2018.02.2768
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Mp83-17 Importance of Maintenance BCG Inclusion for the BCG Unresponsive Classification

Journal of Urology
Urology
2018English

Intravesical BCG Induces CD4 + T-Cell Expansion in an Immune Competent Model of Bladder Cancer

Cancer immunology research
Cancer ResearchImmunology
2017English

Intravesical Therapy – BCG and Beyond

Bladder Cancer
OncologyUrology
2019English

P3.04-20 Correlation of Immune-Related Adverse Events and Response From Immune Checkpoint Inhibitors in Patients With Advanced NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

BCG Instillation Versus Radical Cystectomy for High-Risk NMIBC With Squamous/Glandular Histologic Variants

Scientific Reports
Multidisciplinary
2019English

Granulomatous Prostatitis Diagnosed During Intravesical BCG Treatment

Turk Uroloji Dergisi
Urology
2014English

Effect Sizes in Ongoing Randomized Controlled Critical Care Trials

Critical Care
Critical CareIntensive Care Medicine
2017English

Bilateral Uveitis After Intravesical BCG Immunotherapy for Bladder Carcinoma

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2002English

Immune Checkpoint Inhibition in Patients With Brain Metastases

Annals of Translational Medicine
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy